In xenograft mouse models, IFNA exhibited both anti-proliferative and anti-metastatic effects in prostate cancer, potentially linked to an increase in the E-cadherin to matrix metalloprotease-9 ratio [34]. The gene discussed is CDH1; the disease is prostate carcinoma.